SLU researchers study meningitis vaccine
Saint Louis University scientists are conducting a clinical trial of a vaccine for the last remaining strain of meningitis without a vaccine.
The university is recruiting children ages 10 to 12 to evaluate the safety and effectiveness of the vaccine. Adolescents are the primary carriers of the bacteria that causes the disease.
Meningococcal meningitis is a potentially life-threatening bacterial infection. Flu-like symptoms can progress rapidly, and death can occur within hours.
St. Louis Public Radio is a service of the University of Missouri-St. Louis.